$DCTH
Delcath Systems Inc

2018 Q2 Form 10-Q Financial Statement

#000156459018021739 Filed on August 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q4 2017 Q2
Revenue $858.0K $704.0K $584.0K
YoY Change 46.92% 4.14% 14.29%
Cost Of Revenue $220.0K $170.0K $140.0K
YoY Change 57.14% -5.56% -6.67%
Gross Profit $638.0K $530.0K $449.0K
YoY Change 42.09% 6.0% 24.38%
Gross Profit Margin 74.36% 75.28% 76.88%
Selling, General & Admin $2.640M $1.880M $2.530M
YoY Change 4.35% -21.99% 10.63%
% of Gross Profit 413.79% 354.72% 563.47%
Research & Development $4.089M $3.380M $2.518M
YoY Change 62.39% 36.84% 29.46%
% of Gross Profit 640.91% 637.74% 560.8%
Depreciation & Amortization $100.0K $110.0K $100.0K
YoY Change 0.0% 37.5% 0.0%
% of Gross Profit 15.67% 20.75% 22.27%
Operating Expenses $6.730M $5.254M $5.050M
YoY Change 33.27% 7.62% 19.33%
Operating Profit -$6.092M -$4.725M -$4.601M
YoY Change 32.41% 7.8% 18.86%
Interest Expense -$560.0K $12.50M -$6.950M
YoY Change -91.94% 22.43% 488.98%
% of Operating Profit
Other Income/Expense, Net -$5.000K -$50.00K $0.00
YoY Change -99.65% -100.0%
Pretax Income -$6.660M -$19.24M -$1.940M
YoY Change 243.3% 126.62% -70.91%
Income Tax -$140.0K
% Of Pretax Income
Net Earnings -$6.658M -$19.25M -$1.943M
YoY Change 242.67% 126.8% -70.86%
Net Earnings / Revenue -775.99% -2733.81% -332.71%
Basic Earnings Per Share -$7.26 -$0.75 -$3.50
Diluted Earnings Per Share -$7.26 -$265.9B -$0.01
COMMON SHARES
Basic Shares Outstanding 916.7K 252.3M
Diluted Shares Outstanding 916.7K 252.3M

Balance Sheet

Concept 2018 Q2 2017 Q4 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.280M $4.000M $1.820M
YoY Change -29.67% -9.3% -75.67%
Cash & Equivalents $2.345M $3.999M $1.816M
Short-Term Investments
Other Short-Term Assets $1.410M $2.030M $14.13M
YoY Change -90.02% -92.92% -23.25%
Inventory $1.250M $1.248M $1.040M
Prepaid Expenses
Receivables $400.0K $317.0K $380.0K
Other Receivables $30.00K $0.00 $0.00
Total Short-Term Assets $4.370M $7.589M $17.37M
YoY Change -74.84% -77.78% -35.67%
LONG-TERM ASSETS
Property, Plant & Equipment $1.099M $1.298M $1.230M
YoY Change -10.65% 19.85% 15.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.103M $1.298M $1.230M
YoY Change -10.33% 19.85% -91.45%
TOTAL ASSETS
Total Short-Term Assets $4.370M $7.589M $17.37M
Total Long-Term Assets $1.103M $1.298M $1.230M
Total Assets $5.473M $8.887M $18.60M
YoY Change -70.58% -74.78% -55.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.607M $3.846M $990.0K
YoY Change 466.36% 547.47% 125.51%
Accrued Expenses $5.220M $3.408M $2.230M
YoY Change 134.08% 0.03% 9.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $390.0K $0.00 $12.60M
YoY Change -96.9% -100.0%
Total Short-Term Liabilities $18.10M $7.814M $17.21M
YoY Change 5.17% -78.35% -48.86%
LONG-TERM LIABILITIES
Long-Term Debt $30.00K $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $439.0K $395.0K $530.0K
YoY Change -17.17% -34.6% -25.98%
Total Long-Term Liabilities $439.0K $395.0K $530.0K
YoY Change -17.17% -34.6% -25.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.10M $7.814M $17.21M
Total Long-Term Liabilities $439.0K $395.0K $530.0K
Total Liabilities $18.56M $8.209M $17.74M
YoY Change 4.64% -77.65% -50.66%
SHAREHOLDERS EQUITY
Retained Earnings -$324.3M -$324.8M
YoY Change 16.35%
Common Stock $9.000K $3.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $51.00K $51.00K
YoY Change 0.0%
Treasury Stock Shares $1.00 $1.00
Shareholders Equity -$13.09M $678.0K $870.0K
YoY Change
Total Liabilities & Shareholders Equity $5.473M $8.887M $18.60M
YoY Change -70.58% -74.78% -55.06%

Cashflow Statement

Concept 2018 Q2 2017 Q4 2017 Q2
OPERATING ACTIVITIES
Net Income -$6.658M -$19.25M -$1.943M
YoY Change 242.67% 126.8% -70.86%
Depreciation, Depletion And Amortization $100.0K $110.0K $100.0K
YoY Change 0.0% 37.5% 0.0%
Cash From Operating Activities -$2.840M -$3.740M -$4.320M
YoY Change -34.26% 3.6% 37.14%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K -$150.0K -$220.0K
YoY Change -86.36% 1400.0% 175.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$30.00K -$150.0K -$220.0K
YoY Change -86.36% 650.0% -80.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.400M -1.790M -120.0K
YoY Change -2100.0% -140.04% -105.31%
NET CHANGE
Cash From Operating Activities -2.840M -3.740M -4.320M
Cash From Investing Activities -30.00K -150.0K -220.0K
Cash From Financing Activities 2.400M -1.790M -120.0K
Net Change In Cash -470.0K -5.680M -4.660M
YoY Change -89.91% -776.19% 129.56%
FREE CASH FLOW
Cash From Operating Activities -$2.840M -$3.740M -$4.320M
Capital Expenditures -$30.00K -$150.0K -$220.0K
Free Cash Flow -$2.810M -$3.590M -$4.100M
YoY Change -31.46% -0.28% 33.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 us-gaap Assets
Assets
5473000
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5220000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3408000
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1099000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1298000
CY2017Q4 us-gaap Assets
Assets
8887000
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5607000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3846000
us-gaap Depreciation
Depreciation
127000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
94000
dcth Stock Option Compensation Income Expense
StockOptionCompensationIncomeExpense
-40000
dcth Restricted Stock Compensation Income Expense
RestrictedStockCompensationIncomeExpense
64000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
208000
CY2018Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
387000
CY2017Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0
CY2018Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
27000
CY2017Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
439000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
395000
CY2018Q2 us-gaap Liabilities
Liabilities
18563000
CY2017Q4 us-gaap Liabilities
Liabilities
8209000
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
9000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
311293000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
325516000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-324305000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-324832000
CY2018Q2 us-gaap Treasury Stock Value
TreasuryStockValue
51000
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
51000
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-36000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
42000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-13090000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
678000
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5473000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8887000
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
932159
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
263305
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
932158
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
263304
CY2018Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
1
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
858000
dcth Restricted Stock Compensation Income Expense
RestrictedStockCompensationIncomeExpense
-81000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
-40000
dcth Stock Option Compensation Income Expense
StockOptionCompensationIncomeExpense
46000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-15656
CY2017Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
584000
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
220000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
6730000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
5050000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6092000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4601000
CY2018Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2513000
CY2018Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2826000
CY2017Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2826000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
848
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-15656
CY2017Q4 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
1:350
CY2017Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0029
CY2018Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
1:500
CY2018Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.002
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-81000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4210000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
18306000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-78000
us-gaap Profit Loss
ProfitLoss
527000
us-gaap Profit Loss
ProfitLoss
-13276000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
848
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-20000
dcth Interest Income Earned On Money Market And Operating Accounts
InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts
1000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
238000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15277000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-201000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-110000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9277000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8137000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
276000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-276000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2172000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4210000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
15000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6645000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5969000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-45000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-149000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2716000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2593000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3999000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4409000
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
23532000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
0
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
628000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1283000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1816000
dcth Number Of Distribution Contracts
NumberOfDistributionContracts
1
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
229000
CY2017Q4 us-gaap Security Deposit
SecurityDeposit
50000
CY2018Q2 dcth Value Added Tax And Goods And Services Tax Receivable Current
ValueAddedTaxAndGoodsAndServicesTaxReceivableCurrent
37000
CY2017Q4 dcth Value Added Tax And Goods And Services Tax Receivable Current
ValueAddedTaxAndGoodsAndServicesTaxReceivableCurrent
29000
CY2018Q2 dcth Software Development Cost Current
SoftwareDevelopmentCostCurrent
26000
CY2017Q4 dcth Software Development Cost Current
SoftwareDevelopmentCostCurrent
15000
CY2018Q2 dcth Financing Costs Current
FinancingCostsCurrent
25000
CY2017Q4 dcth Financing Costs Current
FinancingCostsCurrent
70000
CY2018Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
76000
CY2017Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
115000
CY2018Q2 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2017Q4 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5202000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5174000
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4103000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3876000
CY2018Q2 us-gaap Depreciation
Depreciation
100000
CY2017Q2 us-gaap Depreciation
Depreciation
100000
CY2018Q2 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
2304000
CY2017Q4 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
1124000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
221000
CY2018Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
193000
CY2017Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
209000
CY2018Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
836000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
985000
CY2018Q2 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2017Q4 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2018Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
424000
CY2018Q1 dcth Number Of Pre Funded Warrants
NumberOfPreFundedWarrants
76000
CY2018Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
4300000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
0
CY2018Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
6900000
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-619000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-92000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13276000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
dcth Tax Cuts And Jobs Act Of2017 Tax Effect Accounting Complete
TaxCutsAndJobsActOf2017TaxEffectAccountingComplete
false

Files In Submission

Name View Source Status
0001564590-18-021739-index-headers.html Edgar Link pending
0001564590-18-021739-index.html Edgar Link pending
0001564590-18-021739.txt Edgar Link pending
0001564590-18-021739-xbrl.zip Edgar Link pending
dcth-10q_20180630.htm Edgar Link pending
dcth-20180630.xml Edgar Link completed
dcth-20180630.xsd Edgar Link pending
dcth-20180630_cal.xml Edgar Link unprocessable
dcth-20180630_def.xml Edgar Link unprocessable
dcth-20180630_lab.xml Edgar Link unprocessable
dcth-20180630_pre.xml Edgar Link unprocessable
dcth-ex311_9.htm Edgar Link pending
dcth-ex312_7.htm Edgar Link pending
dcth-ex321_6.htm Edgar Link pending
dcth-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending